Literature DB >> 11738260

Internalization of mu-opioid receptors produced by etorphine in the rat locus coeruleus.

E J Van Bockstaele1, K G Commons.   

Abstract

Chronic administration of mu-opioid receptor agonists is known to produce adaptive changes within noradrenergic neurons of the locus coeruleus. Although mu-opioid receptors are densely expressed by locus coeruleus neurons, the effects of acute and chronic administration of agonists on the subcellular distribution of mu-opioid receptors remain poorly understood. Therefore, we examined the ultrastructural distribution of mu-opioid receptor immunoreactivity in the locus coeruleus of rats subjected to either acute morphine, or etorphine, or chronic morphine treatment. In the locus coeruleus of control rats receiving acute saline injections or placebo pellet implants, immunogold-silver labeling for mu-opioid receptors was localized to parasynaptic and extrasynaptic portions of the plasma membranes of perikarya and dendrites. Only 8% of the gold-silver particles analyzed were distributed within the cytoplasm of dendrites and perikarya in vehicle-treated rats. Immunolabeling for mu-opioid receptors was distributed along portions of the plasma membrane that were often apposed by astroglial sheaths. After acute injections of etorphine, there was a dramatic internalization of mu-opioid receptors to intracellular compartments. Quantitative analysis of gold-silver particles indicative of mu-opioid receptors showed that a substantial number of gold particles shifted from the plasma membrane to early endosomes in dendrites from etorphine-treated rats. In dendrites sampled from etorphine-treated rats, 85% of the gold-silver grains indicative of mu-opioid receptor labeling were located in intracellular compartments as compared to 15% that were distributed along the plasma membrane. In animals that received either acute morphine injections or chronic morphine via pellet implantation, no change in the subcellular distribution of immunogold particles indicative of mu-opioid receptors was detected when compared to matched control animals. These results provide the first ultrastructural evidence that mu-opioid receptors are internalized by agonists such as etorphine, but not the partial agonist morphine, in the locus coeruleus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11738260     DOI: 10.1016/s0306-4522(01)00426-2

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  19 in total

1.  Opiate agonist-induced re-distribution of Wntless, a mu-opioid receptor interacting protein, in rat striatal neurons.

Authors:  B A S Reyes; K Vakharia; T N Ferraro; R Levenson; W H Berrettini; E J Van Bockstaele
Journal:  Exp Neurol       Date:  2011-10-06       Impact factor: 5.330

Review 2.  Functional selectivity at the μ-opioid receptor: implications for understanding opioid analgesia and tolerance.

Authors:  Kirsten M Raehal; Cullen L Schmid; Chad E Groer; Laura M Bohn
Journal:  Pharmacol Rev       Date:  2011-08-26       Impact factor: 25.468

Review 3.  Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal.

Authors:  J L Scavone; R C Sterling; E J Van Bockstaele
Journal:  Neuroscience       Date:  2013-04-24       Impact factor: 3.590

4.  Morphine-induced trafficking of a mu-opioid receptor interacting protein in rat locus coeruleus neurons.

Authors:  Kellie M Jaremko; Nicholas L Thompson; Beverly A S Reyes; Jay Jin; Brittany Ebersole; Christopher B Jenney; Patricia S Grigson; Robert Levenson; Wade H Berrettini; Elisabeth J Van Bockstaele
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-12-12       Impact factor: 5.067

5.  In vivo techniques to investigate the internalization profile of opioid receptors.

Authors:  Amynah A Pradhan; Vivianne L Tawfik; Alycia F Tipton; Grégory Scherrer
Journal:  Methods Mol Biol       Date:  2015

Review 6.  Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.

Authors:  John T Williams; Susan L Ingram; Graeme Henderson; Charles Chavkin; Mark von Zastrow; Stefan Schulz; Thomas Koch; Christopher J Evans; Macdonald J Christie
Journal:  Pharmacol Rev       Date:  2013-01-15       Impact factor: 25.468

7.  Interaction of the mu-opioid receptor with GPR177 (Wntless) inhibits Wnt secretion: potential implications for opioid dependence.

Authors:  Jay Jin; Saranya Kittanakom; Victoria Wong; Beverly A S Reyes; Elisabeth J Van Bockstaele; Igor Stagljar; Wade Berrettini; Robert Levenson
Journal:  BMC Neurosci       Date:  2010-03-09       Impact factor: 3.288

8.  Characterization of cannabinoid-1 receptors in the locus coeruleus: relationship with mu-opioid receptors.

Authors:  Jillian L Scavone; Ken Mackie; Elisabeth J Van Bockstaele
Journal:  Brain Res       Date:  2009-11-18       Impact factor: 3.252

9.  Effects of acute agonist treatment on subcellular distribution of kappa opioid receptor in rat spinal cord.

Authors:  Yulin Wang; Wei Xu; Peng Huang; Charles Chavkin; Elisabeth J Van Bockstaele; Lee-Yuan Liu-Chen
Journal:  J Neurosci Res       Date:  2009-05-15       Impact factor: 4.164

10.  Stress-induced intracellular trafficking of corticotropin-releasing factor receptors in rat locus coeruleus neurons.

Authors:  Beverly A S Reyes; Rita J Valentino; Elisabeth J Van Bockstaele
Journal:  Endocrinology       Date:  2007-10-18       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.